Demant reported DKK12.42B in Current Liabilities for its fiscal semester ending in June of 2026.





Current Liabilities Change Date
Demant DKK 12.42B 5B Jun/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
Genmab DKK 1.14B 38M Jun/2026
Getinge SEK 12.03B 3.01B Jun/2026
GN Store Nord DKK 10.82B 4.86B Sep/2026
Lonza CHF 3.57B 421M Dec/2025
Pandora DKK 11.43B 1.1B Sep/2026
Philips EUR 7.91B 485M Sep/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Trinity Biotech USD 143.68M 2.48M Mar/2026